Steven Cohen’s Sanara MedTech SMTI Stock Holding History

Steven Cohen’s Portfolio SMTI Stock Details SMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10,335	Closed	-$178K	–	4539
2026 Q1	$178K	Buy	+10,335	New	+$213K	﹤0.01%	3552

Other funds holding SMTI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

SWM

Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 23.07% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Steven Cohen's SMTI Position: Q2 2026 in Review

Steven Cohen sold out of Sanara MedTech (SMTI) in Q2 2026, closing a stake of 10,335 shares — an estimated $178K sold.

Steven Cohen first reported a position in SMTI in Q1 2026 and held it in 1 quarter. The position peaked at $178K in Q1 2026. 74 funds tracked by Wall St. Rank hold SMTI as of Q2 2026.

Steven Cohen reported no remaining Sanara MedTech position as of Q2 2026 after selling out during the quarter.
Steven Cohen sold 10,335 Sanara MedTech shares in Q2 2026, an estimated $178K.
Steven Cohen first reported a position in Sanara MedTech in Q1 2026 and held it in 1 quarter.
Steven Cohen's Sanara MedTech position peaked at $178K in Q1 2026.
74 funds tracked by Wall St. Rank held Sanara MedTech as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.